Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Gotham Therapeutics and ZoBio Achieve Significant Milestone in Epitranscriptomic Drug Discovery Collaboration

Wednesday, May 22, 2019

Gotham Therapeutics a biotechnology company developing a novel drug class targeting RNAmodifying proteins and ZoBio the leading contract research organization in integrated fragmentbased drug discovery today announced significant progress made as par...

Personalis Enters into a Research Agreement with FLX Bio to Provide Comprehensive Tumor Immunogenomic Profiling for Clinical Study

Tuesday, May 21, 2019

Personalis Inc a leader in advanced genomics for cancer today announced that it has entered into a research agreement with FLX Bio Inc a biopharmaceutical company developing orallyavailable small molecule drugs targeting the immune drivers of cancer...

Kazia Enters Clinical Collaboration for Metastatic Brain Cancer with Alliance for Clinical Trials in Oncology

Tuesday, May 21, 2019

Kazia Therapeutics Limited an Australian oncologyfocused biotechnology company is pleased to announce that it has entered into a collaboration with the Alliance for Clinical Trials in Oncology Foundation Alliance a USbased cancer research network sp...

Intec Pharma Announces Research Collaboration Agreement With Merck

Friday, May 17, 2019

Intec Pharma Ltd today announces it has entered into an agreement with Merck known as MSD outside the United States and Canada to explore using the Accordion Pill AP platform for an undisclosed development program

RegeneRx Partner Receives Patent for New Ophthalmic Formulation of Thymosin Beta 4

Friday, May 17, 2019

RegeneRx Biopharmaceuticals Inc a clinicalstage drug development company focused on tissue protection repair and regeneration reported today that its US joint venture partner and Pan Asian licensee GtreeBNT has been granted a new US patent for a meth...

Vertex and Kymera Therapeutics Establish Strategic Collaboration to Discover and Develop Targeted Protein Degradation Medicines for Serious Diseases

Thursday, May 16, 2019

Vertex Pharmaceuticals Incorporated and Kymera Therapeutics today announced that the two companies have entered into a fouryear strategic research and development collaboration to advance small molecule protein degraders against multiple targets

Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement For Distribution In China

Thursday, May 16, 2019

Cumberland Pharmaceuticals Inc a specialty pharmaceutical company today announced it has entered into an exclusive agreement with Chinas Winhealth Pharma Group for the licensing rights of Acetadote acetylcysteine Injection used to prevent or reduce...

Zymeworks Enters its First ZymeLink™ Antibody-Drug Conjugate Platform Licensing Agreement with Iconic Therapeutics

Wednesday, May 15, 2019

Zymeworks Inc a clinicalstage biopharmaceutical company developing multifunctional biotherapeutics today announced that it has entered into a licensing agreement that grants Iconic Therapeutics Inc Iconic nonexclusive rights to Zymeworks proprietary...

Hoth Therapeutics Signs Term Sheet with Zylö Therapeutics to Acquire a License and Jointly Develop a Product to Treat Lupus

Wednesday, May 15, 2019

Hoth Therapeutics Inc a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitisalso known as eczemaas well as dermatological and chronic wound disorders today announced that...

Onconova Therapeutics Announces License Agreement with HanX Biopharmaceuticals to Develop and Commercialize Rigosertib in Greater China

Tuesday, May 14, 2019

Onconova Therapeutics Inc a Phase stage biopharmaceutical company focused on discovering and developing novel products to treat cancer with an initial focus on myelodysplastic syndromes MDS today announced that it has entered into a license agreement...